# Cost-Effectiveness of Canagliflozin Added to Standard of Care for Treating Diabetic Kidney Disease (DKD) in Patients with Type 2 Diabetes Mellitus (T2DM) in England: Estimates Using the CREDEM-DKD Model

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/cost-effectiveness-of-canagliflozin-added-to-standard-of-care-for-treating/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Michael Willis,Andreas Nilsson,Klas Kellerborg,Philip Ball,Rupert Roe,Shana Traina,Rebecca Beale,Isabelle Newell |
| Citations | 36 |
| DOI | 10.1007/s13300-020-00968-x |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://link.springer.com/content/pdf/10.1007/s13300-020-00968-x.pdf |
| OpenAlex ID | https://openalex.org/W3109444236 |
| PMID | 33263893 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Andreas Nilsson](https://scholariq.org/researchers/andreas-nilsson/)

## Paper journal

- [Diabetes Therapy](https://scholariq.org/journals/diabetes-therapy/)

## Paper primary topic

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Paper topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Diabetes Management and Research](https://scholariq.org/topics/diabetes-management-and-research/)
- [Renal Transplantation Outcomes and Treatments](https://scholariq.org/topics/renal-transplantation-outcomes-and-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.